David Joyner named CVS Health CEO replacing Karen Lynch; preliminary Q3 EPS guide weak

CVS HEALTH Corp

David Joyner appointed President and CEO effective Oct. 17, 2024, succeeding Karen Lynch who resigned.
Roger Farah elevated to Executive Chairman of the Board.
Preliminary Q3 2024 GAAP diluted EPS $0.03-$0.08; adjusted EPS $1.05-$1.10.
Results include $1.1B premium deficiency reserve charge and $1.2B restructuring charge.
MBR expected ~95.2%; prior guidance withdrawn due to elevated medical cost trends.

item 2.02 item 7.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Karen S. Lynch

President and Chief Executive Officer

CVS · CVS HEALTH Corp

Effective: 2024-10-17
Successor: J. David Joyner
Filed: October 18, 2024, 7:59 PM ET

Karen S. Lynch ceased to serve as President and Chief Executive Officer of the Company and resigned as a member of the Board on the same day.

Role change

Roger N. Farah

Executive Chairman of the Board

CVS · CVS HEALTH Corp

Effective: 2024-10-17
Filed: October 18, 2024, 7:59 PM ET

Effective October 17, 2024, the Board has also appointed current Chairman Roger N. Farah as Executive Chairman of the Board.

Appointed

J. David Joyner

President and Chief Executive Officer

CVS · CVS HEALTH Corp

Effective: 2024-10-17
Filed: October 18, 2024, 7:59 PM ET

the Board of Directors (the “ Board ”) of the Company appointed J. David Joyner as President and Chief Executive Officer of the Company, effective as of October 17, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Karen S. Lynch resigned as President and Chief Executive Officer at CVS HEALTH Corp.

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

Karen S. Lynch ceased to serve as President and Chief Executive Officer of the Company and resigned as a member of the Board on the same day.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Roger N. Farah was appointed as Executive Chairman of the Board at CVS HEALTH Corp.

Action: appointed
Role: Executive Chairman of the Board

Exact text from the filing

Effective October 17, 2024, the Board has also appointed current Chairman Roger N. Farah as Executive Chairman of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

J. David Joyner was appointed as President and Chief Executive Officer at CVS HEALTH Corp.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

the Board of Directors (the “ Board ”) of the Company appointed J. David Joyner as President and Chief Executive Officer of the Company, effective as of October 17, 2024.

View on SEC.gov

CVS HEALTH Corp filing history →

Source: SEC EDGAR

accession 0001193125-24-239193

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.